echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > 250,000 people personally test "magic drug" aspirin can reduce the risk of death of cancer patients by 20%

    250,000 people personally test "magic drug" aspirin can reduce the risk of death of cancer patients by 20%

    • Last Update: 2021-08-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Aspirin (acetylsalicylic acid) is one of the three oldest and most widely used classic drugs in the world


    In 1897, Bayer, Germany, synthesized the main substances constituting aspirin for the first time, which promoted the marketing of the drug.


    In 1988, Australian scholars first proposed that aspirin can prevent cancer.


    Recently, a research team from Cardiff University in the United Kingdom published an article titled Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers in eCancerMedicalScience.


    The researchers conducted a systematic retrospective analysis of 118 observational studies covering 18 different types of cancer patients


    Although aspirin is a "magic medicine", any kind of drug can not avoid the side effects.


    The study found that a small number of patients had bleeding, but there is no evidence that patients taking aspirin died due to excessive bleeding


    The association between aspirin use and mortality

    Note: The original text has been deleted

    Reference materials:

    [1]https://doi.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.